🇺🇸 FDA
Patent

US 6118001

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity

expired A61PA61P17/00A61P19/00

Quick answer

US patent 6118001 (Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity) held by Darwin Discovery Limited expires Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Darwin Discovery Limited
Grant date
Tue Sep 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P17/00, A61P19/00, A61P19/04, A61P27/14